Biomarkers in Chronic Arthritis
NCT02909998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 379
Last updated 2016-09-21
Summary
Use of genotyping for the optimization of treatment with biologics in chronic arthritis by looking for an association between certain alleles and response to treatment.
Conditions
- Chronic Arthritis
Interventions
- OTHER
-
Blood sample
Conservation at the end of the blood sample
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Isabelle TOUITOU, MD, PhD · Montpellier Hospital University
Eligibility
- Min Age
- 3 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
More Related Trials
-
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset
NCT05808309 ·Status: WITHDRAWN
-
Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
NCT00321217 ·Status: UNKNOWN
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING
-
Information and Acceptability of Biosimilars
NCT04321291 ·Status: UNKNOWN ·Phase: NA
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
ARTEMIS Synovial Markers in Arthritis Childhood
NCT02505828 ·Status: COMPLETED ·Phase: NA
-
Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis
NCT00213538 ·Status: COMPLETED
-
Genetics and Mechanisms of Rheumatoid Arthritis
NCT01788098 ·Status: COMPLETED
-
Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach
NCT02525042 ·Status: COMPLETED
-
Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers
NCT03033095 ·Status: COMPLETED ·Phase: NA
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis
NCT00976599 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Methotrexate Response - A Pilot Study
NCT01726959 ·Status: COMPLETED
-
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
NCT00512239 ·Status: RECRUITING
-
Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France
NCT02927509 ·Status: COMPLETED
-
Microbial Dysbiosis in Rheumatoid Arthritis
NCT03802890 ·Status: UNKNOWN
-
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
NCT03729674 ·Status: UNKNOWN
-
Identification of New Prognostic Markers in Psoriatic Arthritis
NCT03455166 ·Status: COMPLETED ·Phase: NA
-
Survivin as Predictive Biomarker for RA
NCT03444623 ·Status: UNKNOWN
-
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
NCT05534347 ·Status: RECRUITING
-
Cystatin D Fibrinogen Like Protein 1
NCT05929989 ·Status: NOT_YET_RECRUITING
-
Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases
NCT04655612 ·Status: COMPLETED
-
CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
NCT01402661 ·Status: ENROLLING_BY_INVITATION
-
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
NCT00781469 ·Status: TERMINATED
-
Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis
NCT06880146 ·Status: NOT_YET_RECRUITING ·Phase: NA